(Q52148119)

23 April 2018

title

Resveratrol improves delayed r-tPA treatment outcome by reducing MMPs. (English)

1 reference

23 April 2018

author name string

J Chen

1

1 reference

23 April 2018

Q Bai

2

1 reference

23 April 2018

Z Zhao

3

1 reference

23 April 2018

H Sui

4

1 reference

23 April 2018

X Xie

5

1 reference

23 April 2018

language of work or name

English

0 references

publication date

12 October 2015

1 reference

23 April 2018

Acta Neurologica Scandinavica

published in

1 reference

23 April 2018

volume

134

1 reference

23 April 2018

issue

1

1 reference

23 April 2018

page(s)

54-60

1 reference

23 April 2018

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010

cites work

1 reference

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

Improving reperfusion therapy for acute ischaemic stroke.

21 January 2018

1 reference

Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).

21 January 2018

1 reference

Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke.

21 January 2018

1 reference

Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients.

21 January 2018

1 reference

Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia

21 January 2018

1 reference

Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies

21 January 2018

1 reference

Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain

21 January 2018

1 reference

Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation

21 January 2018

1 reference

Neuroprotective action of resveratrol

21 January 2018

1 reference

Protection against recurrent stroke with resveratrol: endothelial protection

21 January 2018

1 reference

Cerebroprotective potential of resveratrol through anti-oxidant and anti-inflammatory mechanisms in rats

21 January 2018

1 reference

Neuroprotective effect of resveratrol on ischemia/reperfusion injury in rats through TRPC6/CREB pathways

21 January 2018

1 reference

Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-κB-dependent inflammatory/MMP-9 pathway.

21 January 2018

1 reference

Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats.

21 January 2018

1 reference

Dose-dependency of resveratrol in providing health benefits.

21 January 2018

1 reference

Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group

21 January 2018

1 reference

Thrombectomy within 8 hours after symptom onset in ischemic stroke

21 January 2018

1 reference

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction

21 January 2018

1 reference

Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia

21 January 2018

1 reference

Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke

21 January 2018

1 reference

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ANE.12511

1 reference

23 April 2018

PubMed ID

26455907

1 reference

23 April 2018